Reliability of N-terminal proBNP assay in diagnosis of left ventricular systolic dysfunction within representative and high risk populations

Heart

Volumn 90, Issue 8, 2004, Pages 866-870

  Hobbs, F D R ^a   Davis, R C ^a   Roalfe, A K ^a   Hare, R ^a   Davies, M K ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENZYME ASSAY; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FAILURE; HIGH RISK POPULATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RELIABILITY; SCREENING TEST;

ADULT; AGED; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NERVE TISSUE PROTEINS; PEPTIDE FRAGMENTS; REFERENCE VALUES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 3442892135     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2003.014258     Document Type: Article

References (26)

1. Bonneaux L, Barendregt JJ, Meeter K, et al. Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health 1994;84:20-8.
2. Davies MK, Hobbs FDR, Davis RC, et al. Prevalence of left ventricular systolic dysfunction and heart failure in the general population: main findings from the ECHOES (echocardiographic Heart of England screening) study. Lancet 2001;358:439-45.
3. McDanagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997;350:829-33.
4. Ho KKL, Anderson KM, Kannel WB, et al. Survival after onset of congestive heart failure in Framingham heart study subjects. Circulation 1993;88:107-15.
5. Davis R, Hobbs FDR, Kenkre JE, et al. Quality of life in heart failure, as measured by SF-36 health status questionnaire. Eur Heart J 1998;19:S639.
6. Task Force on Heart Failure of the European Society of Cardiology. Guidelines for the diagnosis of heart failure. Eur Heart J 1995;16:741-51.
7. American College of Cardiology/American Heart Association. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on evaluation and management of heart failure) Circulation 1995;92:2764-84.
8. Garg R, Yusuf S, for the Collaborative Group on ACE Inhibitor Trials. Overview of randomised trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6.
9. CIBIS-II Investigators and Committees. The cardiac insufficiency bisoprolol study II. Lancet 1999;353:9-13.
10. Hobbs FDR, Jones MI, Allan TF, et al. European survey of primary care physician perceptions on heart failure diagnosis and management (Euro-HF). Eur Heart J 2000;21:1877-87.
11. The SOLVD investigators. Effect of Enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-91.
12. Pfeffer MA, Brunwald E, Moy LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the survival and ventricular enlargement trial. N Engl J Med 1992;327:669-77.
13. Hobbs FDR. Primary care physicians: champions of or an impediment to optimal care of the patient with heart failure? Eur J Heart Failure 1999;1:1:11-15.
14. Dargie HJ, McMurray JJV. Diagnosis and management of heart failure. BMJ 1994;308:321-8.
15. Remes J, Miettinen H, Reunanen A, et al. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991;12:315-21.
16. Davie AP, Francis CM, Love MP, et al. Value of an electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ 1996;312:222.
17. The NETWORK Investigators. Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. Eur Heart J 1998;19:481-9.
18. Sur DK, Kaye L, Mikus M, et al. Accuracy of electrocardiogram reading by family practice residents. Fam Med 2000;32:315-19.
19. McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left ventricular systolic dysfunction. Lancet 1998;351:9-13.
20. Smith H, Pickering RM, Struthers A, et al. Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study. BMJ 2000;320:906-8.
21. Hobbs FDR, Davis RC, Roalfe AK, et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure: cohort study in representative and high risk community populations. BMJ 2002;324:1498-502.
22. Hewlett Packard Co. HP acoustic quantification user's guide. PN77021-98160/1/2/4. Andover, Massachusetts: Hewlett Packard Corporation.
23. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561-77.
24. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
25. Murdoch DR, McDonagh TA, Bryne J. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: randomised comparison of haemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 1999;138:1126-32.
26. Struthers AD. The diagnosis of heart failure. Heart 2000;84:334-8.